Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1994Journal of Clinical Oncology

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.

View Full Paper
Ask AI
Bookmark
Share

Authors

David Cunningham
David CunninghamRutgers, The State University of New Jersey
Luis Paz‐Ares
Luis Paz‐AresUniversidad Complutense de MadridRPR PowlesNational Cancer Centre Japan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cunningham et al. (1994) studied this question.

synapsesocial.com/papers/6a81fdcd9e5e8e4efb4d7b1ehttps://doi.org/10.1200/jco.1994.12.4.759
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma1990 · 77 citations
  2. 2Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma1993 · 101 citations
  3. 3Prognostic factors with high-dose melphalan for refractory multiple myeloma [see comments]1988 · 60 citations